IFN-gamma-secreting HAdV antigen specific T cells (Case Comprehensive Cancer Center)

N/A

Report date: 2023/10/26 16:03:08

Base Information

Drug NameIFN-gamma-secreting HAdV antigen specific T cells (Case Comprehensive Cancer Center)
Drug Alias NameInterferon (IFN)-gamma-secreting HAdV antigen specific T cellsAntigen-selected, adenovirus-specific T Cells
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionIFN-γ gene transferenceT lymphocyte replacements
TargetsInterferon gamma
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCase Comprehensive Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesCase Comprehensive Cancer Center
Inactive CompaniesN/A
Active IndicationsHematopoietic stem cell transplantation (HSCT)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A